Article information
Full text is only aviable in PDF
References
[1.]
D.I. Wilson, I.E. Cross, C. Wren, P.J. Scambler, J. Goodship.
Minimum prevalence of 22q11 deletions.
Am J Hum Genet, 55 (1994), pp. A169
[2.]
S. Tézenas Du Montcel, H. Mendizabai, S. Aymé, A. Lévy, N. Philip.
Prevalence of 22q11 microdeletion.
J Med Genet, 33 (1996), pp. 719
[3.]
A.K. Ryan, J.A. Goodship, D.I. Wilson, N. Philip, A. Levy, H. Seidel, et al.
Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study.
J Med Genet, 34 (1997), pp. 798-804
[4.]
A.M. Di George.
Congenital absence of the thymus and its immunological consequences: concurrence with congenital hypoparathyroidism.
Birth Defects, 4 (1968), pp. 116-121
[5.]
F. Moreno Izco, E. Zuazo Zamalloa, S. González Alvarado, P. Bereciartu Irastorza.
Síndrome de deleción 22q11: un fenotipo en expansión.
Neurología, 24 (2009), pp. 69-71
[6.]
D. Gothelf, A. Frisch, E. Michaelovsky, A. Weizman, R.J. Shprintzen.
Velo-Cardio-Facial Síndrome.
J Ment Health Res Intellect Disabil, 2 (2009), pp. 149-167
[7.]
N.H. Robin, R.J. Shprintzen.
Defining the clinical spectrum of deletion 22q11.2.
J Pediatr, 147 (2005), pp. 90-96
Copyright © 2011. Sociedad Española de Endocrinología y Nutrición
